92 cases spread to 12 countries! Who Warns: Human-to-human transmission is occurring! Will there be
Madrid (Reuters) - A total of 70 suspected or confirmed cases of monkeypox have been reported in the region, 30 of which have been confirmed by nucleic acid tests and 40 suspected cases are still being confirmed, according to the Spanish public health Minister Escudro.
Monkeypox is known to be a viral zoonosis. Most patients recover within weeks, but some develop severe symptoms and even death.

Viral zoonosis
Monkeypox is a viral zoonosis caused by monkeypox virus (M& # 111nkeypox), a DNA (deoxyribonucleic acid) virus belonging to orthpoxviridae, a family of poxviridae, and a "close relative" of smallpox virus, which has been prevalent in human history for thousands of years. M& # 111nkeypox virus was first discovered in 1958, when a "pox-like" infection emerged in a group of monkeys used for research, hence the name. Since the world Health Organization declared the eradication of smallpox in 1980, m& # 111nkeypox virus has become the most significant orpoxvirus affecting public health.

The smallpox vaccine is effective against monkeypox
According to WHO, the symptoms of monkeypox virus infection are similar to smallpox, but of less clinical severity. The incubation period is usually 6 to 13 days and may be as long as 21 days. Initial symptoms include fever, headache, swollen lymph nodes, muscle aches, and severe fatigue, which helps distinguish monkeypox from smallpox. After a few days, the fever develops into a large skin rash on the face and other parts of the body, and may lead to secondary infections, bronchopneumonia, sepsis, etc.
Monkeypox is usually a self-limited illness, with most patients recovering within a few weeks. Severe cases often occur in children or those with immune deficiency, and are also related to the basic health status of the infected person, the degree of exposure to the virus and the severity of complications. The fatality rate of m& # 111nkeypox has varied widely, ranging from 3% to 6% in recent years.

Studies have shown that smallpox vaccination is 85% effective in preventing monkeypox. In 2019, a vaccine based on the attenuated vaccinia virus was approved to prevent monkeypox, but it has not yet been widely administered. On the treatment side, an earlier fDA-approved anti-smallpox drug, Tecovir, was approved for monkeypox in Europe in 2022 and is not yet widely used.
The recent transmission is "atypical"

The number of countries and cases outside Africa reporting m& # 111nkeypox cases has been increasing in recent days, with many of those infected having no travel history to areas where m& # 111nkeypox is endemic. The WHO said the occurrence of monkeypox cases in multiple "non-endemic countries" with no direct travel links to endemic areas was "atypical" and that it was still investigating the source of infection.
Source: Zhejiang Trade promotion comprehensive collation from Beijing Business Daily, financial Union
Leave a Reply
- INVITATION OF DUBAI LIGHTING FAIR FROM ZJESL
- How to Choose a Reliable Professional LED Lighting Supplier — Taking ZJESL as an Example
- Speed, Precision, Steadiness | ZJESL 2025 Line Skills Challenge
- Discover the Versatility of ATHENA Panel Lights: A Lighting Solution for Every Space!
- Lighting Up Families | ZJESL's Gift of Warmth to Employees